C

Cox Health | Wheeler Heart And Vascular Center

Research site

(Unclaimed)

Location

3800 S. National Ave Suite 540, Springfield, Missouri, United States of America

Site insights

Top conditions

Top treatments

Milvexian

Paclitaxel

Cilastatin

Cilastatin-XNW4107

Platinum

Imipenem

XNW4107-302

Relebactam

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 16 total trials

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling

Acute Coronary Syndrome

Drug: Milvexian

Other: Placebo

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

Enrolling

Ischemic Stroke; Ischemic Attack, Transient

Drug: Placebo

Drug: Milvexian

Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)

This study aims to compare treatment with Imipenem/Cilastatin-XNW4107 (IMI-XNW4107) with imipenem/cilastatin/relebactam (IMI/REL) in participants wit...

Enrolling

Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia

Drug: Combination of Imipenem/Cilastatin and XNW4107

Drug: Imipenem/Cilastatin/Relebactam

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial (PREVENT)

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture...

Enrolling

Open Midline Laparotomy

Device: Phasix™ Mesh